Mao Yi-An, Xu Shihui, Shi Xiaozhou, Jin Yanjia, Pan Zihan, Hao Tian, Li Guoping, Chen Xuerui, Wang Hongdong, Wang Yongtao, Xiao Junjie
Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) and School of Life Science, Shanghai University, Nantong, 226011, China.
Cardiac Regeneration and Ageing Lab, Institute of Cardiovascular Sciences, Shanghai Engineering Research Center of Organ Repair, School of Life Science, Shanghai University, Shanghai, 200444, China.
J Nanobiotechnology. 2025 Aug 19;23(1):573. doi: 10.1186/s12951-025-03623-4.
Tissue regeneration remains one of the most formidable challenges in modern medicine, particularly in the treatment of chronic wounds, organ damage, and degenerative diseases. These conditions are characterized by dysregulated healing, irreversible cell loss, and disrupted microenvironments that are resistant to conventional therapy. Traditional approaches, such as surgical grafts and systemic drug delivery, often fall short due to the limitations in specificity, efficacy, and safety. Emerging technologies, especially microneedles (MNs), nanomedicine, and their integration offer an innovative solution by enabling localized, controlled, and minimally invasive interventions. This review explores the challenges and therapeutic strategies associated with MNs and nanomedicine in tissue regeneration and cancer-related treatment. It highlights recent design innovations, functional diversity of bioengineered MNs, and the transformative potential of combining MNs with nanomedicine for precision regenerative therapies in specific tissues. The future perspectives of MNs and nanomedicine suggest promising avenues for smart and personalized regeneration.
组织再生仍然是现代医学中最严峻的挑战之一,尤其是在慢性伤口、器官损伤和退行性疾病的治疗方面。这些病症的特点是愈合失调、细胞不可逆损失以及微环境紊乱,传统疗法对此难以奏效。传统方法,如手术移植和全身给药,由于特异性、疗效和安全性方面的限制,往往效果不佳。新兴技术,特别是微针(MNs)、纳米医学及其整合,通过实现局部、可控和微创干预,提供了一种创新解决方案。本综述探讨了与微针和纳米医学在组织再生及癌症相关治疗中相关的挑战和治疗策略。它强调了最近的设计创新、生物工程微针的功能多样性,以及将微针与纳米医学相结合用于特定组织的精准再生疗法的变革潜力。微针和纳米医学的未来前景为智能和个性化再生指明了充满希望的途径。
J Nanobiotechnology. 2025-8-19
Int J Nanomedicine. 2025-7-4
Nanomedicine (Lond). 2025-8
Arch Ital Urol Androl. 2025-6-30
Crit Rev Ther Drug Carrier Syst. 2025
AAPS PharmSciTech. 2025-7-8
Adv Mater. 2025-6
Nat Commun. 2025-3-18